BeaverBeads™ Protein A/G Matrix beads product enables Protein A/G to cover superparamagnetic microspheres with high density by using Beaver biological nano-technology. Comparing to similar products currently on the international immunomagnetic beads market, it has more antibody binding sites, smaller usage of beads and less binding with other protein. Thus, it makes immunoprecipitation experiments more efficient. The antibody can be separated from the serum sample by one-step purification, and the purity of the antibody is more than 90%.
| Product name | NO. | Spec | Packing Unit | Unit Price | Add Cart |
| BeaverBeads™ Protein A / Protein G | 70814-5 | 5ml. 10%(v/v),10-30um | bottled | $ | |
| BeaverBeads™ Protein A / Protein G | 70814-100 | 100ml. 10%(v/v),10-30um | bottled | $ | |
| BeaverBeads™ Protein A / Protein G | 70814-500 | 500ml. 10%(v/v),10-30um | bottled | $ | |
| BeaverBeads™ Magrose Protein G | 70814P-5 | 5 mL，10~30 µm | Case | $ | |
| BeaverBeads™ Magrose Protein G | 70814P-100 | 100 mL，10~30 µm | Case | $ | |
| BeaverBeads™ Magrose Protein G | 70814P-500 | 500 mL，10~30 µm | Case | $ | |
| BeaverBeads™ Protein A Antibody Purification | 20102-1 | 30mg/mL | 1 mL, 30mg/mL, 2μm | $ | |
| BeaverBeads™ Protein A Antibody Purification | 20102-5 | 30mg/mL | 5 mL, 30mg/mL, 2μm | $ | |
| BeaverBeads™ Protein A Antibody Purification | 20102-25 | 30mg/mL | 25 mL, 30mg/mL, 2μm | $ | |
| BeaverBeads™ Protein A/G Antibody Purification | 20202-1 | 30mg/mL | 1 mL, 30mg/mL, 2μm | $ | |
| BeaverBeads™ Protein A/G Antibody Purification | 20202-5 | 30mg/mL | 5 mL, 30mg/mL, 2μm | $ | |
| BeaverBeads™ ProteinA/G Antibody Purification | 20202-25 | 30mg/mL | 25 mL, 30mg/mL, 2μm | $ | |
| BeaverBeads™ Magrose ProteinA Antibody Purification | 70804-5 | 10%（v/v） | 5 mL，10% (v/v), 30-150 μm | $ | |
| BeaverBeads™ Magrose ProteinA Antibody Purification | 70804-100 | 10%（v/v） | 100 mL,10%(v/v), 30-150 μm | $ | |
| BeaverBeads™ Magrose ProteinA Antibody Purification | 70804-500 | 10%（v/v） | 500 mL,10%(v/v), 30-150 μm | $ | |
| BeaverBeads™ Magrose ProteinG Antibody Purification | 70805-5 | 10%（v/v） | 5 mL,10%(v/v), 30-150 μm | $ | |
| BeaverBeads™ Magrose ProteinG Antibody Purification | 70805-100 | 10%（v/v） | 100 mL, 10%(v/v), 30-150 μm | $ | |
| BeaverBeads™ Magrose ProteinG Antibody Purification | 70805-500 | 10%（v/v） | 500 mL, 10%(v/v), 30-150 μm | $ |
1. Highly effective antibody binding capacity and ultra-low non-specific adsorption performance
Protein A Matrix beads extract the purity of antibody IgG from 10-fold diluted human serum, which is substantially the same or even higher than the purity of IgG extracted directly from serum.
2. Time saving, simple and mild
The picture below shows the BeaverBeads ™ bead application flow diagram
Comparison with chromatographic - agarose gel purification
1. No centrifugation, magnetic separation can be used, and the use of the chromatograph-agarose gel purification system can greatly shorten the operating time
2. Avoid the error of the packing loss caused by repeated suction fluid
3. Avoid damage to active protein by mechanical shearing force in centrifugation
3. High product stability
BeaverBeads ™ Protein A Matrix Magnetic Beads Stability Test. The magnetic beads were incubated at 37 ℃ for 8 weeks, and the antibody binding efficiency was not attenuated, which indicated that the beads had good stability.
4. Antibody elution system is closer to neutral
This product uses an optimized elution buffer to elute antibodies at pH 4.5, greatly reducing the risk of acid-sensitive antibodies being damaged in low pH elution environments.
5. Very low protein A ligand off rate
Protein A residues in antibody purification products for Beaver Beads ™ beads are lower than US FDA standards (20 ppm). And has been certified by the foreign well-known foreign products no significant difference.
6. Reusable
BeaverBeads ™ antibody purified beads can be reused and regenerated, and maintain high antibody binding efficiency. After 15 uninterrupted purification operations, 75% of the lgG binding capacity was maintained, and the antibody binding capacity was restored to the original 90% after regeneration treatment.
